Back to results

CompletedPhase 2

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

NCT03228394

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Marinus Research Site

Little Rock, Arkansas, United States

+15 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2017-06-27
Enrollment: 91 participants
Sponsor: Marinus Pharmaceuticals
Purpose: treatment

Locations (16)

Marinus Research SiteLittle Rock, Arkansas, United States
Marinus Research SiteCosta Mesa, California, United States
Marinus Research SiteLemon Grove, California, United States
Marinus Research SiteSan Diego, California, United States
Marinus Research SiteJacksonville, Florida, United States
Marinus Research SiteAtlanta, Georgia, United States
Marinus Research SiteDecatur, Georgia, United States
Marinus Research SiteLeawood, Kansas, United States
Marinus Research SiteOverland Park, Kansas, United States
Marinus Research SiteNew York, New York, United States
Marinus Research SiteDayton, Ohio, United States
Marinus Research SiteHouston, Texas, United States
Marinus Research SiteIrving, Texas, United States
Marinus Research SiteOrem, Utah, United States
Marinus Research SiteSalt Lake City, Utah, United States
Marinus Research SiteRichmond, Virginia, United States

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression — TrialFind